Brand Name :
Ventolin HFA, Proventil, Accuneb, ProAir Digihaler
Synonyms :
salbutamol
Class :
Beta 2 agonists
Dosage Forms & Strengths
Tablet
2mg
4mg
Extended-release tablet
4mg
8mg
Nebulizer solution
0.63mg/3ml
1.25mg/3ml
Metered dose powder inhaler with e;ectronic module
90mcg/actuation
Metered dose powder inhaler
90mcg/actuation
Aerosol Metered dose inhaler
90mcg/actuation
Aerosol Metered dose inhaler
180mcg inhaled orally every 4 to 6 hours. Do not exceed 12 inhalations for 24 hours
Tablet:2-4mg orally every 6-8 hours. Do not exceed 32mg/day
Nebulizer solution:2.5mg twice a day/thrice a day whenever necessary
1.25-5mg every 4 to 8 hours when necessary for quick relief
Extended-release tablet:8mg orally every 12 hours. Do not exceed 32mg/day
chronic obstructive pulmonary disease (COPD)
Aerosol Metered dose inhaler
1 to 2 inhalations in 2-3 doses every hour, then every 2 to 4 hours
Nebulizer solution:10 to 20 mg through nebulization for 10 minutes
Dosage Forms & Strengths
Tablet
2mg
4mg
Extended-release tablet
4mg
8mg
Nebulizer solution
0.63mg/3ml
1.25mg/3ml
Metered dose powder inhaler with e;ectronic module
90mcg/actuation
Metered dose powder inhaler
90mcg/actuation
Aerosol Metered dose inhaler
90mcg/actuation
Aerosol Metered dose inhaler
<4 years: Safety and efficacy not established
>4 years: 90-180mcg inhaled orally every 4 to 6 hours. Do not exceed 12 inhalations for 24 hours
Powder Metered dose inhaler
<4 years: Safety and efficacy not established
>4 years: 90-180mcg inhaled orally every 4 to 6 hours. Do not exceed 12 inhalations for 24 hours
Tablet
<6 years:0.3-0.6mg/kg/day orally divided every 8 hours
6-12 years: 2mg orally every 6-8 hours
>12 hours: 2-4mg orally every 6-8 hours. Do not exceed 32mg/day
Nebulizer solution
<2 years:0.2-0.6mg/kg/day divided every 6-8 hours
2-12 years(<15kg): 2.5mg/0.5ml every 6-8 hours
>12 years:2.5mg every 6 to 8 hours when necessary
Refer adult dosing
may increase the hypertensive effect of sympathomimetics
may increase the hypertensive effect of sympathomimetics
may decrease the therapeutic effect of beta2 agonists
may increase the toxic effect of sympathomimetics
may increase the toxic effect of airway disease treating agents
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the tachycardic effect of beta2 agonists
may increase the tachycardic effect of beta2 agonists
may decrease the bronchodilatory effect of beta2 agonists
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the arrhythmogenic effect of sympathomimetics
may increase the hypokalemic effect of beta2 agonists
may increase the hypokalemic effect of beta2 agonists
may increase the hypokalemic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the hypokalemic effect of beta2 agonists
may increase the hypokalemic effect of beta2 agonists
may increase the hypokalemic effect of beta2 agonists
may increase the hypokalemic effect of beta2 agonists
may increase the toxic effect of beta2 agonists
may increase the risk or severity of hypertension when combined
may decrease salbutamol elimination, raising serum levels
may enhance the risk of hypertension when combined with salbutamol
Mechanism of action
salbutamol is a medication used as a bronchodilator to help manage asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It works by relaxing the muscles in the airways, which helps to open up the air passages and make breathing easier
salbutamol is a type of medication called a short-acting beta-2 agonist. It works by binding to beta-2 receptors in the smooth muscle cells of the airways, causing the cells to relax and widen the air passages. This action helps improve airflow in and out of the lungs
Spectrum
The spectrum of activity of salbutamol is primarily focused on the respiratory system, where it can help to relieve symptoms of asthma, COPD, and other conditions that cause difficulty breathing. Salbutamol effectively treats bronchoconstriction, a tightening of the airway muscles that makes breathing harder. It can also be used to prevent exercise-induced bronchoconstriction
Frequency defined:
>10%
Insomnia in children 6-12 years (11%)
Tremor (20%)
Nervousness (20%)
1-10%
Fever (1.6-9%)
Vomiting (7%)
Dizziness (1-7%)
Allergic reaction (4%)
Epistaxis in children (3%)
Urinary tract infections (3%)
Flatulence (<3%)
Pain (2.7%)
Hyperactivity (1-2%)
Lymphadenopathy (<2%)
Sweating (<2%)
Dysphonia (1%)
Nervousness
Nausea(10%)
Bronchospasm (8%)
Headache (4-7%)
Cough (5%)
Otitis media (3.3%)
Increased appetite (3%)
Dry mouth (<3%)
Increased sweating (<3%)
Dyspepsia (1-2%)
Chills
Ocular pruritis (<2%)
Conjunctivitis (1%)
Flu syndrome
<1%
Epistaxis in adults
Epigastric pain
Hyperactivity in children
Frequency undefined
Hypersensitivity
Increased blood glucose levels
Sleeplessness
Contraindications
Caution
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology
It is a short-acting beta-2 adrenergic receptor agonist that relaxes the smooth muscle in the lungs’ airways, leading to bronchodilation. salbutamol is a selective beta-2 agonist, which means it targets the beta-2 receptors in the lungs and has little effect on the beta-1 receptors in the heart
The binding of salbutamol to the beta-2 receptors causes an increase in intracellular cyclic adenosine monophosphate (cAMP) levels in the smooth muscle cells, leading to relaxation and dilation of the airways
Pharmacodynamics
The pharmacodynamics of salbutamol is focused on its ability to selectively target and stimulate the beta-2 receptors in the lungs, leading to relaxation of the airway smooth muscle and improved airflow. This mechanism of action has made salbutamol a valuable medication for treating respiratory conditions such as asthma, COPD, and bronchitis.
Pharmacokinetics
Absorption
It can be administered by several routes, including inhalation, nebulization, and oral administration. The onset of action varies depending on the route of administration, with inhalation having the fastest onset (25 minutes for Ventolin HFA) and oral administration having the slowest onset (2-3 hours). The duration of action is generally 4-6 hours for oral administration, and the peak plasma time varies depending on the route of administration
Distribution
It is relatively lipophilic and has a volume of distribution of approximately 90 liters. It is only 10% protein-bound, so it is highly distributed throughout the body
Metabolism
It is primarily metabolized in the liver by conjugation with glucuronic acid, and oxidative pathways metabolize a small percentage
Elimination/Excretion
The half-life of salbutamol varies depending on the route of administration, with inhalation having a half-life of 3-8 hours and oral administration having a half-life of 3.7-5 hours. It is eliminated from the body primarily through urine
Administration
salbutamol can be administered through several routes, including inhalation, nebulization, and oral administration. The specific route of administration will depend on the condition being treated, the severity of symptoms, and the patient’s needs
Inhalation: Inhalation is the most common route of administration for salbutamol, especially for treating asthma and other respiratory conditions. Salbutamol can be delivered via a metered-dose inhaler (MDI) or a dry powder inhaler (DPI). The MDI is the most common method and delivers a fixed dose of salbutamol with each actuation. On the other hand, the DPI requires the patient to inhale a specific amount of powder.
In both cases, the patient should exhale completely, then inhale deeply while pressing down on the inhaler to release the medication. The patient should hold their breath for 10 seconds, then exhale slowly. The number of inhalations and frequency of use will depend on the patient’s specific condition and the severity of symptoms
Nebulization: Nebulization is another method of delivering salbutamol to the lungs. This method is often used in the hospital setting, especially for patients who cannot use an inhaler. A nebulizer converts the liquid medication into a fine mist that the patient can inhale through a mask or mouthpiece
Patient information leaflet
Generic Name: salbutamol
Why do we use salbutamol?
salbutamol is a medication that is primarily used to treat and prevent symptoms of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis